Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type description Rank Interaction Map Gene Network Comparison Type Filtered green red network_comparison
Results: HTML CSV LaTeX Showing element 1080 to 1129 of 3228 in total 
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
galectin-9 (hom-hd-21) (ecalectin). [source:swissprot;acc:o00182]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
973\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8566.29\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7810.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09682\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gamma adducin (adducin-like protein 70). [source:swissprot;acc:q9uey8]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1365\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6255.04\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5799.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07862\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gamma enolase (ec 4.2.1.11) (2-phospho-d-glycerate hydro-lyase) (neural enolase) (nse) (enolase 2). [source:swissprot;acc:p09104]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
943\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7241\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6597.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09746\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-1 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p14867]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
587\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
7644.63\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6739.83\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.13425\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-2 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p47869]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
580\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-3 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p34903]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
588\vspace{3pt}}&&&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-4 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p48169]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
584\vspace{3pt}}&&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6739.82\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-6 subunit precursor (gaba(a) receptor). [source:swissprot;acc:q16445]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
581\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor epsilon subunit precursor (gaba(a) receptor). [source:swissprot;acc:p78334]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
585\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor gamma-1 subunit precursor (gaba(a) receptor). [source:swissprot;acc:q8n1c3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
579\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
7644.62\vspace{3pt}}}&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor gamma-2 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p18507]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
582\vspace{3pt}}&&&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor gamma-3 subunit precursor (gaba(a) receptor). [source:swissprot;acc:q99928]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
577\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6739.81\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-butyrobetaine,2-oxoglutarate dioxygenase (ec 1.14.11.1) (gamma-butyrobetaine hydroxylase) (gamma-bbh). [source:swissprot;acc:o75936]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1348\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6640.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6153.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07921\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-interferon inducible lysosomal thiol reductase precursor (gamma-interferon-inducible protein ip-30). [source:swissprot;acc:p13284]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3101\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-sarcoglycan (gamma-sg) (35 kda dystrophin-associated glycoprotein) (35dag). [source:swissprot;acc:q13326]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
741\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6434.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5768.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11554\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-snap-associated factor 1; rab11-interacting protein. [source:refseq;acc:nm\_015470]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1450\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6031.05\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5602.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07659\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-soluble nsf attachment protein (snap-gamma) (n-ethylmaleimide- sensitive factor attachment protein, gamma). [source:swissprot;acc:q99747]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
500\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4093.05\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4682.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1441\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ganglioside-induced differentiation-associated protein 1-like 1. [source:refseq;acc:nm\_024034]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
776\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6533.36\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5874.76\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.11211\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
ganglioside-induced differentiation-associated protein 1. [source:refseq;acc:nm\_018972]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
779\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gastricsin precursor (ec 3.4.23.3) (pepsinogen c). [source:swissprot;acc:p20142]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1188\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4776.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4392.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08732\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gbp protein isoform a. [source:refseq;acc:nm\_017870]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
23\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1894.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
699.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.7072\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gc-rich sequence dna-binding factor homolog. [source:swissprot;acc:q9y5b6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1685\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6508.45\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6088.07\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06905\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gcn5-like protein 1 (rt14 protein). [source:swissprot;acc:p78537]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2432\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8453.84\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8154.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03671\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gdp-fucose protein o-fucosyltransferase 1 precursor (ec 2.4.1.221) (peptide o-fucosyltransferase) (o-fuct-1). [source:swissprot;acc:q9h488]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3125\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gdp-mannose pyrophosphorylase a; mannose-1-phosphate guanylyltransferase (gdp). [source:refseq;acc:nm\_013335]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1520\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5673.81\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5283.8\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07381\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
gdp-mannose pyrophosphorylase b isoform 1; mannose-1-phosphate guanylyltransferase; amphoterin induced gene 3. [source:refseq;acc:nm\_013334]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1519\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
general control of amino acid synthesis protein 5-like 2 (ec 2.3.1.-) (histone acetyltransferase gcn5) (hsgcn5). [source:swissprot;acc:q92830]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1944\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7648.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7210.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06079\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
general vesicular transport factor p115 (transcytosis associated protein) (tap) (vesicle docking protein). [source:swissprot;acc:o60763]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2156\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6000.03\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5701.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0523\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
geranylgeranyl pyrophosphate synthetase (ggpp synthetase) (ggppsase) (geranylgeranyl diphosphate synthase) [includes: dimethylallyltransferase (ec 2.5.1.1); geranyltranstransferase (ec 2.5.1.10); farnesyltranstransferase (ec 2.5.1.29)]. [source:swissprot;acc:o95749]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1203\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4696.04\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4322.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08638\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
geranylgeranyl transferase type i beta subunit (ec 2.5.1.-) (type i protein geranyl-geranyltransferase beta subunit) (ggtase-i-beta). [source:swissprot;acc:p53609]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2366\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5492.28\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5265.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04298\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
geranylgeranyl transferase type ii beta subunit (ec 2.5.1.-) (rab geranylgeranyltransferase beta subunit) (rab geranyl- geranyltransferase beta subunit) (rab gg transferase beta) (rab ggtase beta). [source:swissprot;acc:p53611]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2963\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
germ cell specific y-box binding protein; contrin. [source:refseq;acc:nm\_015982]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2096\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7051.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6682.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05522\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
germ cell-less. [source:refseq;acc:nm\_022471]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2465\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8003.67\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7764.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03075\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gk001 protein. [source:refseq;acc:nm\_020198]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
540\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12069.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10603.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13825\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
glia maturation factor gamma (gmf-gamma). [source:swissprot;acc:o60234]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1205\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6459.79\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5946.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08635\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
glioma pathogenesis-related protein (glipr) (rtvp-1 protein). [source:swissprot;acc:p48060]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2953\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
glioma tumor suppressor candidate region gene 2 protein (p60). [source:swissprot;acc:q9nzm5]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3104\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
glioma-amplified sequence-41; numa binding protein 1. [source:refseq;acc:nm\_006530]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3007\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 1 (ec 2.6.1.16) (hexosephosphate aminotransferase 1) (d-fructose-6- phosphate amidotransferase 1) (gfat 1) (gfat1). [source:swissprot;acc:q06210]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1426\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5777.33\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5362.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07729\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 2 (ec 2.6.1.16) (hexosephosphate aminotransferase 2) (d-fructose-6- phosphate amidotransferase 2) (gfat 2) (gfat2). [source:swissprot;acc:o94808]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1409\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5773.37\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5358.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07749\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
glucosamine-6-phosphate isomerase (ec 3.5.99.6) (glucosamine-6- phosphate deaminase) (gnpda) (glcn6p deaminase) (oscillin). [source:swissprot;acc:p46926]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3058\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
glucosamine-6-phosphate isomerase. [source:refseq;acc:nm\_138335]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2861\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
glucose-6-phosphate 1-dehydrogenase (ec 1.1.1.49) (g6pd). [source:swissprot;acc:p11413]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1549\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6464.16\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6025.86\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07274\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
glucose-6-phosphate isomerase (ec 5.3.1.9) (gpi) (phosphoglucose isomerase) (pgi) (phosphohexose isomerase) (phi) (neuroleukin) (nlk) (sperm antigen-36) (sa-36). [source:swissprot;acc:p06744]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1725\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6463.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6051.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06818\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
glutamate carboxypeptidase-like protein 2 precursor. [source:swissprot;acc:q96kn2]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1258\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6774.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6251.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08363\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
glutamate decarboxylase, 65 kda isoform (ec 4.1.1.15) (gad-65) (65 kda glutamic acid decarboxylase). [source:swissprot;acc:q05329]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
499\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4093.05\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4682.87\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.1441\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
glutamate decarboxylase, 67 kda isoform (ec 4.1.1.15) (gad-67) (67 kda glutamic acid decarboxylase). [source:swissprot;acc:q99259]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
501\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
glutamate dehydrogenase 1, mitochondrial precursor (ec 1.4.1.3) (gdh). [source:swissprot;acc:p00367]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2502\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6738.23\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6562.71\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02675\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
glutamate dehydrogenase 2, mitochondrial precursor (ec 1.4.1.3) (gdh). [source:swissprot;acc:p49448]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2501\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
glutamate--cysteine ligase catalytic subunit (ec 6.3.2.2) (gamma- glutamylcysteine synthetase) (gamma-ecs) (gcs heavy chain). [source:swissprot;acc:p48506]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2364\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6539.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6822.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04324\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/